Data / Medical devices / Ireland / Beckman Coulter Ireland Inc
Beckman Coulter Ireland Inc: FDA-registered device maker in O CALLAGHANS MILLS Clare, Ireland, 54 510(k) clearances
Beckman Coulter Ireland Inc is registered with the FDA (registration 9680746) in O CALLAGHANS MILLS Clare, Ireland. It lists 100 device types. The FDA files 54 510(k) clearances under its listings, the newest dated March 23, 2022. 4 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 9680746
- FEI number
- 1000206808
- Address
- Lismeehan, O CALLAGHANS MILLS Clare, Ireland, --
- Owner or operator
- BECKMAN COULTER, INC. (2050012)
- Roles
- Contract manufacturer, Manufacturer, Specification developer
- First device listed
- December 14, 1977
- Registered through
- 2026
- Brand names listed
- 442655 Lactate Dehydrogenase Reagent (LD 2 x 200), 442660 Lactate Dehydrogenase Reagent (LD-P 2 x 200), 442831 PVT 2, 472055 PVT 5, 442830 PVT 3, 445865 SYNCHRON Systems Wash Concentrate II, 445967 SYNCHRON CX Systems Antifoam, 447040 IMMAGE Immunochemistry Systems BUF 2 Buffer 2, 447050 IMMAGE Immunochemistry Systems BUF 3 Buffer 3, 447060 IMMAGE Immunochemistry Systems Wash Solution and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| March 23, 2022 | K220178 | Total Immunoglobulin E (IgE) | DGC | Substantially Equivalent | Beckman Coulter, Inc. | accessdata.fda.gov |
| January 16, 2019 | K182651 | HbA1c Advanced | PDJ | Substantially Equivalent | Beckman Coulter Ireland, Inc. | accessdata.fda.gov |
| January 9, 2017 | K161508 | Ceruloplasmin | DDB | Substantially Equivalent | Beckman Coulter Ireland, Inc. | accessdata.fda.gov |
| October 15, 2014 | K142346 | Urine/CSF Albumin, Urine/CSF Albumin Calibrator | DCF | Substantially Equivalent | Beckman Coulter Ireland, Inc. | accessdata.fda.gov |
| July 11, 2014 | K141388 | SYSTEM CALIBRATER | JIX | Substantially Equivalent | Beckman Coulter Ireland, Inc. | accessdata.fda.gov |
| June 30, 2014 | K141374 | BICARBONATE CALIBRATOR | JIT | Substantially Equivalent | Beckman Coulter Ireland, Inc. | accessdata.fda.gov |
| October 9, 2013 | K131546 | AU BICARBONATE REAGENT | KHS | Substantially Equivalent | Beckman Coulter Ireland, Inc. | accessdata.fda.gov |
| October 12, 2012 | K120199 | GLYCOSYLATED HEMOGLOBIN ASSAY; CLINICAL CHEMISTRY | LCP | Substantially Equivalent | Beckman Coulter, Inc. | accessdata.fda.gov |
| February 7, 2011 | K103373 | SYNCHRON SYSTEMS CHOLINESTERASE (CHEX) MODEL A53722 | DIH | Substantially Equivalent | Beckman Coulter, Inc. | accessdata.fda.gov |
| December 11, 2009 | K092505 | BECKMAN COULTER FERRITIN REAGENT, MODEL: OSR61203 | DBF | Substantially Equivalent | Beckman Coulter, Inc. | accessdata.fda.gov |
| September 5, 2008 | K080435 | OLYMPUS DIRECT BILIRUBIN REAGENT, MODEL OSR6X181 | CIG | Substantially Equivalent | Olympus Life Science Research Europa GmbH (Europa) | accessdata.fda.gov |
| February 11, 2008 | K073490 | OLYMPUS IGG REAGENT | CFN | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| February 11, 2008 | K073489 | OLYMPUS IGA REAGENT | CFN | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| February 11, 2008 | K073487 | OLYMPUS IGM REAGENT | CFN | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| June 11, 2007 | K070453 | OLYMPUS D-DIMER REAGENT, MODEL OSR6X135, OLYMPUS D-DIMER CALIBRATOR, MODEL ODR3033, OLYMPUS D-DIMER CONTROL | GHH | Substantially Equivalent | Olympus Life & Material Science Europa GmbH (Irish | accessdata.fda.gov |
| June 4, 2007 | K070835 | OLYMPUS CK-MB REAGENT | JHY | Substantially Equivalent | Olympus Life & Material Science Europa GmbH (Irish | accessdata.fda.gov |
| April 6, 2007 | K062862 | OLYMPUS URIC ACID REAGENT, MODEL OSR6X98 | KNK | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| March 23, 2007 | K063804 | OLYMPUS TRIGLYCERIDE TEST SYSTEM | CDT | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| October 5, 2006 | K061575 | OLYMPUS CALCIUM ARSENAZO REAGENT, OSR60117, OSR61117, OSR65117 | CJY | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| June 6, 2006 | K060201 | OLYMPUS RF LATEX CALIBRATOR, AND OLYMPUS RF LATEX REAGENT WITH MODEL(S): ODC0028, AND OSR61105. | DHR | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| August 22, 2005 | K051564 | OLYMPUS CRP LATEX REAGENT, OSR6199; OLYMPUS CRP LATEX CALIBRATOR NORMAL SET, ODC0026; OLYMPUS CRP LATEX CALIBRATOR HIGH | NQD | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| January 31, 2005 | K043460 | OLYMPUS LYOPHILIZED CHEMISTRY CALIBRATORS DR0070 AND DR0071 | JIX | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| December 23, 2004 | K043202 | OLYMPUS CREATINE KINASE REAGENT OSR6179/OSR6279 | CGS | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| July 16, 2004 | K041793 | OLYMPUS UNSATURATED IRON BINDING CAPCITY REAGENT, OSR6124/0SR6524 | JMO | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| April 8, 2004 | K040692 | OLYMPUS HDL CHOLESTEROL REAGENT, OSR6195/OSR6295 AND OLYMPUS HDL CHOLESTEROL CALIBRATOR ODC0023 | JIT | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| March 10, 2004 | K040471 | OLYMPUS LDL CHOLESTEROL REAGENT, OSR6196/OSR6296; OLYMPUS LDL CHOLESTEROL CALIBRATOR, ODC0024 | JIT | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| January 30, 2004 | K033910 | OLYMPUS URINE CALIBRATOR | JIX | Substantially Equivalent | Cliniqa Corporation | accessdata.fda.gov |
| August 21, 2003 | K032285 | OLYMPUS PREALBUMIN CALIBRATOR, ODR3029 | JIT | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| February 21, 2003 | K030045 | OLYMPUS CHOLINESTERASE REAGENT (CATALOG NUMBER OSR6114) | DIH | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| November 24, 1999 | K993444 | K-ASSAY ALPHA-1 AT | DEM | Substantially Equivalent | Kamiya Biomedical Co. | accessdata.fda.gov |
| August 19, 1999 | K992086 | OLYMPUS SERUM PROTEIN MULTICALIBRATOR 2 | JIX | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| May 11, 1999 | K991136 | B-2-MICROGLOBULIN IMMUNOLOGICAL TEST SYSTEM | JZG | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| May 7, 1998 | K981305 | OLYMPUS SERUM PROTEIN MULTICALIBRATOR | JIX | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| February 6, 1997 | K963139 | OLYMPUS TRANSFERRIN IMMUNOTURBIDIMETRIC REAGENT | DDD | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| January 14, 1997 | K963424 | OLYMPUS LIPASE REAGENT | CDT | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| October 18, 1996 | K962582 | OLYMPUS C4 IMMUNOTURBIDIMETRIC REAGENT | DBI | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| October 18, 1996 | K962409 | OLYMPUS C3 IMMUNOTURBIDIMETRIC REGENT | CZW | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| February 14, 1996 | K954537 | OLYMPUS C-REACTIVE PROTEIN IMMUNOTURBIDIMETRIC REAGENT | DCN | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| July 5, 1995 | K952425 | OLYMPUS APOLIPOPROTEIN A1 IMMUNOTURBIDIMETRIC REAGENT | JHN | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| June 5, 1995 | K952466 | OLYMPUS APOLIPOPROTEIN B IMMUNOTURBIDIMETRIC REAGENT | JHN | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| December 27, 1994 | K944407 | OLYMPUS MAGNESIUM REAGENT | JGJ | Substantially Equivalent | Olympus America, Inc. | accessdata.fda.gov |
| February 5, 1993 | K925339 | OLYLMPUS ALANINE AMINOTRANSFERASE REAGENT | CKA | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| January 26, 1993 | K925155 | OLYMPUS ASPARTATE AMINOTRANSFERASE REAGENT | CIT | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| December 18, 1992 | K924691 | OLYMPUS IRON REAGENT | JIY | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| December 3, 1992 | K924964 | OLYMPUS TOTAL BILIRUBIN REAGENT | CIG | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| December 3, 1992 | K924601 | OLYMPUS GLUCOSE REAGENT | CFR | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| November 30, 1992 | K924963 | OLYMPUS DIRECT BILIRUBIN REAGENT | CIG | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| November 25, 1992 | K924693 | OLYMPUS BUN REAGENT | CDQ | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| November 19, 1992 | K925057 | OLYMPUS INORGANIC PHOSPHORUS REAGENT | CEO | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| November 18, 1992 | K925156 | OLYMPUS ALKALINE PHOSPHATASE REAGENT | CJE | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| October 19, 1992 | K924692 | OLYMPUS CREATININE REAGENT | CGX | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| October 19, 1992 | K924339 | OLYMPUS AMYLASE REAGENT | CIW | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| July 21, 1992 | K921718 | OLYMPUS ISE MODULE | JGS | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
| July 17, 1992 | K922369 | OLYMPUS ALBUMIN REAGENT | CIX | Substantially Equivalent | Olympus Corp. | accessdata.fda.gov |
Recalls
Recall events where this establishment is the recalling firm, matched on its FEI.
| Initiated | Event | Class | Status | Product | Reason | Source |
|---|---|---|---|---|---|---|
| December 8, 2025 | 98094 | Class II | Ongoing | The LDL-Cholesterol assay is comprised of two distinct phases. In phase one a unique detergent solubilizes cholesterol from non-LDL- lipoprotein particles. This cholesterol is consumed by cholesterol esterase, cholestero | Beckman Coulter identified that LDL Cholesterol OSR6x96 is not meeting the performance claim listed in the Instructions for Use (IFU). LDL Cholesterol reagent showed clinically significant interference due to triglyceride concentration up to 1500 mg/dL may cause a maximum positive bias of up to 28.8% in low LDL Cholesterol samples (concentration 80 mg/dL) an | accessdata.fda.gov |
| October 14, 2025 | 97842 | Class II | Ongoing | BECKMAN COULTER BICARBONATE REF: OSR6137 OSR6237 OSR6637 OSR6x37 Bicarbonate is a system reagent for the quantitative determination of Bicarbonate in human serum and plasma on Beckman Coulter AU analyzers. | Bicarbonate reagent may generate falsely high Bicarbonate results due to interference with Lactate Dehydrogenase (LDH) in the test sample. | accessdata.fda.gov |
| April 23, 2025 | 96746 | Class III | Ongoing | Apo B Reagent, REF: OSR6143 | The product Value Assignment Sheet (VAS) is used in calibration of the device. An erroneous value was included in the VAS which has the potential to generate an incorrect APO B patient result which could exceed the total allowable error for the APO B assay (11.6%). The error results in results with a positive bias up to 42%. However, based on the mitigating | accessdata.fda.gov |
| September 6, 2023 | 93206 | Class II | Ongoing | AU/DxC AU Chemistry Transferrin REF: OSR6152 Immune complexes formed in solution scatter light in proportion to their size, shape and concentration. Turbidimeters measure the reduction of incident light due to reflection | The firm has identified that the Transferrin reagent does not meet the Instructions for Use (IFU) reagent on-board stability claims, which may cause control failures and/or erroneous patient samples results. The Complaint handling unit has received a total of 2 safety cases (CASE-2023-02027212 and CASE-2023-02045278) and 99 quality cases with the failure mod | accessdata.fda.gov |
Compare with other makers
- All makers of Enzyme Immunoassay, Phenobarbital
- All makers of Analyzer, Chemistry (Photometric, Discrete), For Clinical Use
- All makers of Electrode, Ion Specific, Potassium
- All makers of Bromcresol Purple Dye-Binding, Albumin
- All makers of Conductivity Rate, Urea Nitrogen
- All makers of Enzyme Immunoassay, Benzodiazepine
Updated January 21, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.